Drug & intervention

nebivolol

RxCUI 31555

Clinical trials59
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Nebivolol

Nebivolol is a beta blocker used to treat high blood pressure and heart failure. As with other β-blockers, it is generally a less preferred treatment for high blood pressure. It may be used by itself or with other blood pressure medication. It is taken by mouth. Common side effects include dizziness, feeling tired, nausea, and headaches. Serious side effects may include heart failure and bronchospasm. Its use in pregnancy and breastfeeding is not recommended. It works by blocking β1-adrenergic receptors in the heart and dilating blood vessels. Nebivolol was patented in 1983 and came into medical use in 1997. It is available as a generic medication in the United Kingdom. In 2023, it was the 191st most commonly prescribed medication in the United States, with more than 2 million prescriptions.

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Determination of Drug Levels for Pharmacotherapy of Heart FailureNCT06035978 · 2024-03-01
UNKNOWN
Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each MonotherapyNCT05513937 · 2022-05-12
COMPLETED
Effect of Different Antihypertensive Drugs on Central Blood PressureNCT05328310 · 2019-01-06
UNKNOWN
Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With AnthracyclinesNCT05728632 · 2019-01-01
UNKNOWN
Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic StrokeNCT03655964 · 2018-08-20
COMPLETED
Comparative Effects of Nebivolol and Carvedilol on Diastolic Function in the Elderly Heart Failure PatientsNCT02619526 · 2016-12-01
UNKNOWN
Treatment of OSA Associated Hypertension With Nebivolol or HydrochlorothiazideNCT02710071 · 2015-01-01
COMPLETED
Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart FailureNCT02053246 · 2014-01-01
TERMINATED
24 Hour Ambulatory Cardiac Oxygen ConsumptionNCT05170061 · 2013-02-01
COMPLETED
CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients.NCT01771406 · 2013-02-01
UNKNOWN
Non-invasive Haemodynamic Assessment in HypertensionNCT01996085 · 2013-01-01
COMPLETED
Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension TreatmentNCT01758263 · 2012-10-01
UNKNOWN
The Effects of Nebivolol on the NO-system in Patients With Essential HypertensionNCT01679652 · 2012-08-01
COMPLETED
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?NCT01605370 · 2012-06-01
TERMINATED
Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of HeartNCT01961323 · 2012-03-01
COMPLETED
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular DystrophyNCT01648634 · 2012-02-13
COMPLETED
Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)NCT01595516 · 2012-02-01
COMPLETED
The Impact of Nebivolol Versus Metoprolol on Quality of LifeNCT01441570 · 2012-02-01
TERMINATED
Safety Study of Nebivolol for COPD PatientsNCT01939990 · 2012-01-01
WITHDRAWN
Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)NCT01415531 · 2011-08-01
COMPLETED
Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood PressureNCT01499134 · 2011-08-01
COMPLETED
Nebivolol and the Endothelin (ET)-1 SystemNCT01395329 · 2011-05-01
COMPLETED
Nebivolol Versus Metoprolol: Sodium SensitivityNCT00992056 · 2010-12-01
COMPLETED
Comparative Study of the Effects of Telmisartan and NebivololNCT02057328 · 2010-12-01
UNKNOWN
An Advanced Echocardiographic Evaluation of NebivololNCT01206439 · 2010-09-01
TERMINATED
Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive PatientsNCT01501929 · 2010-08-01
COMPLETED
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of HypertensionNCT01202175 · 2010-07-01
COMPLETED
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant PatientsNCT01157234 · 2010-07-01
COMPLETED
A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial FunctionNCT01522950 · 2010-05-01
COMPLETED
Nebivolol in Patients With Systolic Stage 2 HypertensionNCT01057251 · 2010-03-01
COMPLETED
Blood Pressure Effects of Nebivolol Versus Lisinopril in New Onset or Worsening Hypertension Induced by BevacizumabNCT01076140 · 2010-02-01
WITHDRAWN
Nebivolol, Lifestyle Modification and Arterial StiffnessNCT01920282 · 2010-01-01
COMPLETED
Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor CellsNCT01041287 · 2009-12-01
COMPLETED
The Effect of Nebivolol on Endothelial Dysfunction in African Americans With HypertensionNCT01049009 · 2009-12-01
COMPLETED
Impact of Nebivolol on Central Aortic PressureNCT01051947 · 2009-12-01
WITHDRAWN
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic FunctionNCT01056718 · 2009-11-01
COMPLETED
Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With HypertensionNCT00999752 · 2009-10-01
COMPLETED
Regulatory Nebilet PMSNCT01077661 · 2009-10-01
COMPLETED
Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of LifeNCT00999102 · 2009-10-01
COMPLETED
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive PatientsNCT01502787 · 2009-04-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.